🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST

Jazz Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,7184,2684,0693,8343,6593,094
Revenue Growth
13.48%4.88%6.12%4.78%18.26%30.91%
Cost of Revenue
419.85355.35310.7284.13267.13217.68
Gross Profit
4,2983,9123,7583,5503,3922,877
Selling, General & Admin
1,5341,4981,4161,3071,3991,399
Research & Development
788.09741.49851.06818.39555.41476.33
Amortization of Goodwill & Intangibles
683.86654.66627.31608.28599.17525.77
Operating Expenses
3,0062,8942,8942,7342,5532,401
Operating Income
1,2921,018864.14816.23839.14475.26
Interest Expense
-260.35-280.85-344.4-354.54-299.74-280.57
Interest & Investment Income
92.585.8106.365.111.51.8
Earnings From Equity Investments
-0.23-0.73-1.66-3.01-9.92-0.71
Currency Exchange Gain (Loss)
1.73-2.57-8.188.79-19.01-4.35
EBT Excluding Unusual Items
1,249819.72616.21532.57521.97191.43
Merger & Restructuring Charges
-157.95-176.95-137.51-156.95-326.88-304.99
Asset Writedown
----61.7-133.65-
Legal Settlements
--323.5----
Pretax Income
259.61-628.59468.69294.92-382.71-113.55
Income Tax Expense
53.66-272.44-91.43-119.91-158.65216.12
Earnings From Continuing Operations
205.95-356.15560.12414.83-224.06-329.67
Net Income
205.95-356.15560.12414.83-224.06-329.67
Net Income to Common
205.95-356.15560.12414.83-224.06-329.67
Net Income Growth
--35.02%---
Shares Outstanding (Basic)
636162636360
Shares Outstanding (Diluted)
676166726360
Shares Change
9.53%-7.61%-8.41%15.23%4.77%5.62%
EPS (Basic)
3.28-5.849.066.55-3.58-5.52
EPS (Diluted)
3.10-5.848.656.10-3.58-5.52
EPS Growth
--41.75%---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,6221,2971,3581,0681,243750.87
Free Cash Flow Per Share
24.3221.2720.5714.8219.8712.58
Gross Margin
91.10%91.67%92.36%92.59%92.70%92.97%
Operating Margin
27.39%23.86%21.24%21.29%22.93%15.36%
Profit Margin
4.37%-8.34%13.77%10.82%-6.12%-10.65%
Free Cash Flow Margin
34.37%30.39%33.37%27.86%33.97%24.27%
EBITDA
2,0111,7141,5241,4551,4691,028
EBITDA Margin
42.62%40.17%37.46%37.95%40.13%33.22%
D&A For EBITDA
718.6696.3660.07638.7629.47552.48
EBIT
1,2921,018864.14816.23839.14475.26
EBIT Margin
27.39%23.86%21.24%21.29%22.93%15.36%
Effective Tax Rate
20.67%-----
Revenue as Reported
4,7184,2684,0693,8343,6593,094
Advertising Expenses
-105.6107.492.2108.8161.5
SEC Filings: 10-K · 10-Q